Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial 
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings 
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease 
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth 
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
SAN FRANCISCO, April 23, 2018 -- A newly published market research report from Neurotech Reports predicts that the global market for neurotechnology products will be $8.4 billion in 2018 and grow to $13.3 billion by 2022, a 12-percent compound annual growth rate. The report, titled The Market for Neurotechnology: 2018-2022, tracks U.S. and worldwide sales of neurotechnology products in four major categories: neuromodulation, neuroprosthetics, neurorehabilitation, and neurosensing. Neurotech Reports has been tracking the growth of the neurotechnology market since 2001, longer than any other research firm in this space.
The largest segment of the global neurotechnology market is neuromodulation systems, which will grow from $4.7 billion in 2018 to $7.6 billion in 2022. Worldwide sales of neuroprosthetics systems will grow from $2.1 billion in 2018 to $3.3 billion in 2022, according to the report.
For the first time, Neurotech Reports projects that Medtronic is no longer the market leader in sales of spinal cord stimulation systems. Abbott, which acquired St. Jude Medical last year, will have the largest share of the crowded SCS market in 2018, with Boston Scientific, Medtronic, and Nevro close behind. Medtronic will retain its leadership in the deep brain stimulation market, but steadily lose market share to new players by 2020.
“The neurotechnology industry is currently undergoing dramatic changes in competitive landscape, more so than any other time in the 18 years that we have been covering this market,” said James Cavuoto, editor and publisher of Neurotech Reports. “With several new technologies and new applications on the horizon, we expect to see continued changes in the years ahead.”
The Market for Neurotechnology: 2018-2022 is available from Neurotech Reports for $2495 (single reader), $3295 (2-5 readers), or $4595 (6-10 readers). The report is available to premium subscribers of Neurotech Business Report at no additional charge. To order, visit http://www.neurotechreports.com/pages/reportsumm.html or contact Neurotech Reports at 415 546 1259.
MEDIA ONLY CONTACT:
James Cavuoto
Neurotech Reports
+1-415-546-1259
[email protected]
